Myopia-control contact lenses and methods relating thereto

US12443054B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12443054-B2
Application numberUS-202318097295-A
CountryUS
Kind codeB2
Filing dateJan 16, 2023
Priority dateJan 21, 2022
Publication dateOct 14, 2025
Grant dateOct 14, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An ophthalmic lens (112′, 200) for use in preventing or slowing the development or progression of myopia comprises an optic zone (202) for focusing light from distant point objects to a focal surface. The optic zone comprises a diffractive lens (206) for manipulating the longitudinal chromatic aberration properties of the light proximate the focal surface.

First claim

Opening claim text (preview).

The invention claimed is: 1. An ophthalmic lens for use in preventing or slowing the development or progression of myopia, the ophthalmic lens comprising an optic zone for focusing light from distant point objects to a focal surface, wherein the optic zone comprises a diffractive lens for manipulating the longitudinal chromatic aberration properties of the light proximate the focal surface, the optic zone comprises an annular region and a central region, the central region comprises said diffractive lens, the annular region has a greater optical power than the base power of the central region, the annular region does not comprise a diffractive lens for manipulating the longitudinal chromatic aberration properties of the light, and the diffractive lens is configured to reverse or increase the longitudinal chromatic aberration caused by the natural eye. 2. The ophthalmic lens according to claim 1 , wherein the diffractive lens is configured to cancel the longitudinal chromatic aberration caused by the natural eye. 3. The ophthalmic lens according to claim 1 , wherein the diffractive lens has a positive optical power. 4. The ophthalmic lens according to claim 1 , wherein the diffractive lens has an optical power of between +2.0 dioptre and +8.0 dioptre. 5. The ophthalmic lens according to claim 1 , wherein the diffractive lens has an optical power of between +3.0 dioptre and +3.4 dioptre. 6. The ophthalmic lens according to claim 1 , wherein the optical power of the diffractive lens varies by at least 1.5 dioptre over a wavelength range of 400 nm to 700 nm. 7. The ophthalmic lens according to claim 1 , wherein the diffractive lens has an optical power of between +6.8 dioptre and +7.2 dioptre. 8. The ophthalmic lens according to claim 1 , wherein the optical power of the diffractive lens varies by at least 3.0 dioptre over a wavelength range of 400 nm to 700 nm. 9. The ophthalmic lens according to claim 1 , wherein the diffractive lens comprises a central zone surrounded by a plurality of concentric ring-shaped zones. 10. The ophthalmic lens according to claim 9 , wherein the central zone has a diameter of between 1.0 mm and 1.4 mm. 11. The ophthalmic lens according to claim 9 , wherein the width of each successive ring-shaped zone is less than the immediately preceding ring-shaped zone. 12. The ophthalmic lens according to claim 1 , wherein the ophthalmic lens is a contact lens. 13. The ophthalmic lens according to claim 12 , wherein an optical phase across each zone of the diffractive lens varies over an interval of 2π radians. 14. The ophthalmic lens according to claim 1 , wherein the ophthalmic lens is a contact lens and wherein the contact lens comprises an elastomer material, a silicone elastomer material, a hydrogel material, or a silicone hydrogel material, or mixtures thereof. 15. The ophthalmic lens according to claim 1 , wherein the ophthalmic lens is a moulded contact lens. 16. The ophthalmic lens according to claim 1 , wherein optic zone has a base optical power of between 0.5 dioptre and −15.0 dioptres. 17. The ophthalmic lens according to claim 1 , wherein the focus of the annular region lies on a proximal focal surface, and the focus of the central region lies on a distal focal surface, which is further away from the posterior surface of the contact lens than the proximal focal surface. 18. The ophthalmic lens according to claim 1 , wherein the focus of the annular region and the focus of the central region share a common optical axis. 19. The ophthalmic lens according to claim 1 , wherein the ophthalmic lens is a contact lens and wherein the refractive index of the contact lens material is between 1.40 and 1.44. 20. A method of manufacturing the ophthalmic lens according to claim 1 , the method comprising: forming a lens which comprises an optic zone for focusing light from distant point objects to a focal surface, wherein the optic zone comprises a diffractive lens for manipulating the longitudinal chromatic aberration properties of the light proximate the focal surface, the optic zone comprises an annular region and a central region, the central region comprises said diffractive lens, the annular region has a greater optical power than the base power of the central region, the annular region does not comprise a diffractive lens for manipulating the longitudinal chromatic aberration properties of the light, and the diffractive lens is configured to reverse or increase the longitudinal chromatic aberration caused by the natural eye. 21. A method of reducing progression of myopia, the method comprising: providing the ophthalmic lens according to claim 1 to a myopic person who is able to accommodate for varying near distances. 22. The method of claim 21 , further comprising providing a plurality of the ophthalmic lenses to a myopic person who is able to accommodate for varying near distances, wherein the diffractive lenses of the plurality of ophthalmic lenses have differing optical powers, such that each ophthalmic lens causes a different longitudinal chromatic aberration manipulation.

Assignees

Inventors

Classifications

  • Myopia progression prevention · CPC title

  • Correction of higher order and chromatic aberrations, wave front measurement and calculation · CPC title

  • Diffractive and Fresnel lenses or lens portions · CPC title

  • with pattern for identification or with cosmetic or therapeutic effects (methods and processes take preference, e.g. printing, marking or copying processes B41M; identification in general G09F3/00; producing decorative effects in general B44C; surface treatment of glass C03C15/00 - C03C23/00; positioning or marking of lenses B24B13/0055) · CPC title

  • G02C7/049Primary

    Contact lenses having special fitting or structural features achieved by special materials or material structures · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12443054B2 cover?
An ophthalmic lens (112′, 200) for use in preventing or slowing the development or progression of myopia comprises an optic zone (202) for focusing light from distant point objects to a focal surface. The optic zone comprises a diffractive lens (206) for manipulating the longitudinal chromatic aberration properties of the light proximate the focal surface.
Who is the assignee on this patent?
Coopervision Int Ltd
What technology area does this patent fall under?
Primary CPC classification G02C7/049. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).